Cue Biopharma Inc (CUE)
1.05
+0.02
(+1.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Total Assets (Quarterly): 44.81M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 44.81M |
| June 30, 2024 | 42.33M |
| March 31, 2024 | 53.95M |
| December 31, 2023 | 61.53M |
| September 30, 2023 | 68.89M |
| June 30, 2023 | 73.16M |
| March 31, 2023 | 81.68M |
| December 31, 2022 | 91.28M |
| September 30, 2022 | 76.30M |
| June 30, 2022 | 84.75M |
| March 31, 2022 | 90.70M |
| December 31, 2021 | 83.40M |
| September 30, 2021 | 78.88M |
| June 30, 2021 | 89.67M |
| March 31, 2021 | 88.72M |
| December 31, 2020 | 99.53M |
| Date | Value |
|---|---|
| September 30, 2020 | 106.62M |
| June 30, 2020 | 101.35M |
| March 31, 2020 | 60.65M |
| December 31, 2019 | 71.60M |
| September 30, 2019 | 45.21M |
| June 30, 2019 | 41.76M |
| March 31, 2019 | 45.19M |
| December 31, 2018 | 45.36M |
| September 30, 2018 | 44.58M |
| June 30, 2018 | 53.11M |
| March 31, 2018 | 59.33M |
| December 31, 2017 | 66.95M |
| September 30, 2017 | 6.295M |
| June 30, 2017 | 10.24M |
| December 31, 2016 | 16.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
42.33M
Minimum
Jun 2024
106.62M
Maximum
Sep 2020
77.49M
Average
80.28M
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 140.44M |
| GlycoMimetics Inc | 15.70M |
| FibroGen Inc | 264.42M |
| Cidara Therapeutics Inc | 162.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.44M |
| Shareholders Equity (Quarterly) | 25.37M |
| Debt to Equity Ratio | 0.2086 |
| Current Ratio | 2.219 |
| Net Debt Paydown Yield | 2.10% |